Anticoagulants in the prevention of embolic stroke. Part I

Geriatrics
|February 1, 1987
PubMed

Insights

Patients with cardiac conditions like atrial fibrillation may benefit from anticoagulants after a stroke. CT scans help determine if anticoagulation is appropriate for secondary stroke prevention in these high-risk individuals.

Area of Science:

  • Cardiology
  • Neurology
  • Radiology

Background:

  • Patients with specific cardiac lesions face a high risk of cerebral emboli.
  • Conditions include atrial fibrillation, rheumatic mitral valve disease, myocardial infarction, prosthetic heart valves, and dilated cardiomyopathy.
  • Anticoagulants can prevent cerebral infarction in many high-risk patients.

Purpose of the Study:

  • To evaluate the role of CT scans in guiding anticoagulation therapy after a cardiac embolic stroke.
  • To determine optimal timing and patient selection for anticoagulation in secondary stroke prevention.

Main Methods:

  • Review of CT scans and cerebrovascular pathology in patients with clinical stroke.
  • Analysis of patient data to correlate imaging findings with anticoagulation decisions.

Main Results:

  • CT scans are crucial for deciding on anticoagulation post-cardiac embolic stroke.
  • Cerebral infarct, identified via CT, is more informative than arterial occlusion for treatment decisions.
  • Findings guide the timing and consideration of anticoagulants for secondary prevention.

Conclusions:

  • CT imaging findings, specifically cerebral infarcts, are key to managing anticoagulation for secondary stroke prevention in patients with cardiac embolic sources.
  • This approach optimizes treatment decisions for patients at risk of recurrent embolic events.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.